News

Abbott's New Glucose Monitor: A Game Changer for Consumers

Abbott's New Glucose Monitor: A Game Changer for Consumers

Abbott Launches Innovative Glucose Monitoring Solution

Abbott has recently made a significant impact in the health technology field with the introduction of its eagerly awaited over-the-counter continuous glucose monitoring system called Lingo, now available in the United States. This state-of-the-art device is specifically designed for consumers aged 18 and older who do not use insulin.

Exploring the Lingo Monitoring System

The Lingo glucose monitoring system provides three affordable payment options tailored to meet various consumer needs. Users can choose to buy the device for $49 for a two-week supply, $89 for a four-week supply, or $249 for a complete 12-week package. This flexible pricing allows individuals to select a plan that aligns best with their lifestyle and monitoring preferences.

Regulatory Approval and Its Impact on the Market

A major milestone was achieved in June when Abbott obtained clearance from the FDA for the Lingo system, enabling its market launch. This approval highlights Abbott’s dedication to improving patient outcomes by delivering advanced medical technologies that are both effective and accessible. Consequently, consumers can now conveniently monitor their glucose levels in a manner that aligns with their personal health goals.

Advancing Health Technology

The introduction of the Lingo glucose monitor represents a significant advancement in the ever-evolving realm of health technology. It empowers individuals to take charge of their health with ease, reflecting a broader trend towards consumer empowerment in personal healthcare. Abbott’s innovative strategy is setting a new benchmark in the healthcare sector, emphasizing user-friendly and cost-effective solutions.

Frequently Asked Questions

What is the Lingo glucose monitor?

The Lingo is an over-the-counter continuous glucose monitoring system designed by Abbott for individuals aged 18 and older who do not require insulin.

How much does the Lingo cost?

There are three payment options for the Lingo: $49 for two weeks, $89 for four weeks, and $249 for 12 weeks.

When did Abbott receive FDA approval for the Lingo?

Abbott secured FDA clearance for the Lingo system in June, allowing for its launch in the U.S. market.

Who can use the Lingo glucose monitor?

The Lingo is intended for consumers who are 18 years and older and are not currently using insulin.

What are the benefits of continuous glucose monitoring?

Continuous glucose monitoring provides real-time insights into blood sugar levels, helping users make informed decisions about their diet and lifestyle to maintain optimal health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Encore Boston Harbor Workers Triumph After 62-Day Strike

Updated Category News Views 190

Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...

Continue Reading
Beverly Hills Body Academy: A New Era in Contouring

Updated Category News Views 30

Setting New Standards in Body Contouring It's no secret that Beverly Hills is all about luxury and cutting-edge trends. So, when the Beverly Hills Body Academy™ (BHBA) sets up shop in this glitzy locale, it's a pretty loud statement in the world of body contouring. This isn't just another vanity-driven operation; it's about pioneering advancements in the field of body...

Continue Reading
Senstar Boasts Robust Q3 Growth Amid Global Demand

Updated Category News Views 150

A Standout Quarter for Senstar Technologies How often do you see a company jumping 37% in revenue year-over-year? Not every day, that’s for sure. But that's exactly what's happening with Senstar Technologies Corporation (NASDAQ: SNT). For the third quarter of 2026, they've pulled in $13.1 million compared to last year’s $9.5 million. And that's not just some fluke –...

Continue Reading
Used Truck Inventory Shrinks as Auction Values Rise

Updated Category News Views 124

October's Tailspin in Used Truck Inventory If you've been around the block in the trucking industry, the latest from Sandhills Global might just knock your socks off. Their October rundown is out, and it's looking bleak for anyone trying to grab a used truck or trailer at a bargain. We're seeing a real crunch in inventory, and that’s an understatement. Navigating a...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 83

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
F&G Boosts Dividend for Investors in Strong Signal

Updated Category News Views 214

Ring the Bell: Dividend Hike from F&G F&G Annuities & Life (NYSE: FG) just raised its dividend, and every investor worth their salt knows that means something. A 4% bump up to $0.26 per common share might not sound like a fanfare, but in the land of finance, it's an indication that this company thinks it's riding a positive wave. It’s like getting a little bonus in your...

Continue Reading
Esperto's Space Health Tech Eyes Terrestrial Gains

Updated Category News Views 45

The cosmos isn't just a playground for astronauts. It's a proving ground for the next wave of medical innovation, courtesy of Esperto Medical. They're trotting into uncharted territory with the Translational Research Institute for Space Health (TRISH) grant in hand, determined to transform healthcare both in space and on our own turf. Groundbreaking Tech for Extreme...

Continue Reading
Bank of America Faces Class Action for Securities Fraud

Updated Category News Views 97

Bank of America's Costly Missteps So, Bank of America (NYSE:BAC) has managed to paint itself into a corner again—this time with a whopping $1.2 billion fine from the U.S. Department of the Treasury. The buzz isn't great. It’s about violations of anti-money laundering and sanctions laws affecting national security. On October 13, 2026, this filthy laundry was aired,...

Continue Reading
Array Digital's Q3 2026 Earnings: Strategic Wins and Challenges

Updated Category News Views 109

From Towers to Earnings: Array Digital's 2026 Path Array Digital Infrastructure, Inc. (NYSE:AD) just rolled out its Q3 2026 numbers, and honestly, it's a mixed bag. This company is one of those handy barometers for the telecom infrastructure market, especially now that it's a full-blown tower company. They've pitched an earnings call for the early birds at 9 a.m. CT...

Continue Reading
RCMA Makeup Makes Bold Retail Move with Ulta.com Debut

Updated Category News Views 122

RCMA Makeup: A Longstanding Industry Insider You know when a brand’s been around the block since the 60s, it’s got staying power. RCMA Makeup’s been a snug fit in the toolbox of professional makeup artists for over six decades. This ain't some fly-by-night operation. They’ve thrived on word of mouth—no flashy ads or promotional stunts. Just rock-solid reputation...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Mobility Chair Redefines User Experience and Safety

Updated Category News Views 101

Introducing an Innovative Mobility Solution In the quest for improved independence and mobility, an inventive mind has come forth with a groundbreaking solution—the WILLY CHAIR. This innovative mobility chair has been designed with the user's ease and control in mind, enhancing mobility while ensuring safety. Transforming Movement with the WILLY CHAIR The WILLY CHAIR...

Continue Reading
Uncovering May 2025's Leading Mobile Apps Across EMEA Regions

Updated Category News Views 270

Revolutionizing Mobile App Insights in EMEA In recent years, mobile applications have transformed how we communicate, shop, and entertain ourselves. Companies like Pixalate are at the forefront of enhancing the mobile app ecosystem by providing clear insights into the apps that capture user attention the most. The latest rankings showcase the top-performing mobile apps in...

Continue Reading
Empowering Eczema Management: ATOPIYO Launches in the U.S.

Updated Category News Views 156

Empowering Eczema Management: ATOPIYO Launches in the U.S. 11-time award winner, university-backed, delivers what 31M patients need most — visual tracking, peer support, AI analysis Living with eczema goes beyond physical symptoms—it can impact mental well-being and daily life significantly. ATOPIYO, the leading eczema management app from Japan, is now introducing its...

Continue Reading
Integrum's Innovative Marketing Strategy Highlights BondedMatrix

Updated Category News Views 176

Integrum Introduces Global Marketing Strategy at AOPA Assembly Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), a leading provider of the OPRA™ Implant System, has rolled out an innovative global marketing strategy during the American Orthotic & Prosthetic Association's (AOPA) National Assembly. This pivotal initiative emphasizes BondedMatrix™, a term...

Continue Reading
TopGum Welcomes Raviv Zoller as Chairman of the Board

Updated Category News Views 176

TopGum Welcomes Raviv Zoller to Lead as Chairman of the Board Raviv Zoller brings nearly 30 years of international executive experience; his appointment reflects TopGum's commitment to long-term growth plans. TopGum Industries Ltd. (TASE: TPGM), known globally for its innovative gummy-format dietary supplements, has announced the significant appointment of Raviv Zoller as...

Continue Reading